Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:56PM EDT. Market open.
| Previous close | 20.19 |
| Open | 20.05 |
| Bid | 19.63 x 100 |
| Ask | 19.71 x 100 |
| Day's range | 19.62 - 20.50 |
| 52-week range | 13.02 - 22.09 |
| Volume | |
| Avg. volume | 394,356 |
| Market cap | 1.394B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 151.15 |
| EPS (TTM) | 0.13 |
| Earnings date | 23 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.80 |
GlobeNewswireKiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 10:40 a.m. Pacific Time (1:40 p.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kinik
Simply Wall St.Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report
It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just...
Simply Wall St.Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
© 2024 Yahoo. All rights reserved.